Which ICD-O edition incorporated the WHO classification of hematopoietic and lymphoid neoplasms?

Prepare for your Cancer Registry Test. Study with flashcards and multiple choice questions, each question includes hints and explanations. Be exam-ready!

Multiple Choice

Which ICD-O edition incorporated the WHO classification of hematopoietic and lymphoid neoplasms?

Explanation:
The edition that integrated the WHO classification of hematopoietic and lymphoid neoplasms is the third edition of ICD-O. This edition was designed to align ICD-O’s morphology codes with the World Health Organization’s hematopoietic/lymphoid classification, bringing the histology categories used by cancer registries into the WHO framework. That means many subtypes defined by WHO were mapped into specific ICD-O morphology codes, enabling more consistent and comparable reporting across registries and over time. Earlier editions used older, separate schemes for hematopoietic and lymphoid neoplasms and did not reflect the WHO classifications, while later updates build on that integration but the first formal alignment with WHO’s hematopoietic/lymphoid classification occurred with the third edition.

The edition that integrated the WHO classification of hematopoietic and lymphoid neoplasms is the third edition of ICD-O. This edition was designed to align ICD-O’s morphology codes with the World Health Organization’s hematopoietic/lymphoid classification, bringing the histology categories used by cancer registries into the WHO framework. That means many subtypes defined by WHO were mapped into specific ICD-O morphology codes, enabling more consistent and comparable reporting across registries and over time.

Earlier editions used older, separate schemes for hematopoietic and lymphoid neoplasms and did not reflect the WHO classifications, while later updates build on that integration but the first formal alignment with WHO’s hematopoietic/lymphoid classification occurred with the third edition.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy